The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
Sign Up to like & getrecommendations! Published in 2021 at "Aesthetic surgery journal"
DOI: 10.1093/asj/sjaa382
Abstract: BACKGROUND PrabotulinumtoxinA is a 900-kDa botulinum toxin type A produced by Clostridium botulinum. OBJECTIVES The authors sought to investigate the safety of prabotulinumtoxinA for treatment of glabellar lines. METHODS This was a multicenter, open-label, repeat-dose,… read more here.
Keywords: severe glabellar; treatment; safety; study drug ... See more keywords
The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
Sign Up to like & getrecommendations! Published in 2021 at "Aesthetic surgery journal"
DOI: 10.1093/asj/sjaa383
Abstract: BACKGROUND PrabotulinumtoxinA is a 900-kDa botulinum toxin type A produced by Clostridium botulinum. OBJECTIVES The authors sought to investigate the safety of prabotulinumtoxinA for treatment of glabellar lines. METHODS This was a multicenter, open-label, repeat-dose,… read more here.
Keywords: severe glabellar; treatment; safety; study drug ... See more keywords
PrabotulinumtoxinA for Treatment of Millennials With Moderate to Severe Glabellar Lines: Post Hoc Analyses of the Phase III Clinical Study Data
Sign Up to like & getrecommendations! Published in 2022 at "Dermatologic Surgery"
DOI: 10.1097/dss.0000000000003456
Abstract: Supplemental Digital Content is Available in the Text. BACKGROUND The use of esthetic products by millennials is increasing, yet published clinical trial data in this population are limited. OBJECTIVE To compare the efficacy and safety… read more here.
Keywords: severe glabellar; glabellar lines; moderate severe; post hoc ... See more keywords
Subject satisfaction and psychological well‐being with escalating abobotulinumtoxinA injection dose for the treatment of moderate to severe glabellar lines
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Cosmetic Dermatology"
DOI: 10.1111/jocd.14906
Abstract: Previous studies indicate that the efficacy and durability of a single AbobotulinumtoxinA (ABO) treatment for moderate to severe glabellar lines may be enhanced with increasing dose, while safety outcomes remain consistent with those of the… read more here.
Keywords: moderate severe; severe glabellar; treatment moderate; glabellar lines ... See more keywords
PrabotulinumtoxinA-xvfs for the Treatment of Moderate-to-Severe Glabellar Lines
Sign Up to like & getrecommendations! Published in 2020 at "Annals of Pharmacotherapy"
DOI: 10.1177/1060028020943527
Abstract: Objective PrabotulinumtoxinA-xvfs (Jeuveau), a botulinum toxin type A, was approved by the Food and Drug Administration for the temporary improvement in the appearance of moderate-to-severe glabellar lines in February 2019. This article will review phase… read more here.
Keywords: severe glabellar; prabotulinumtoxina; prabotulinumtoxina xvfs; glabellar lines ... See more keywords